1. Home
  2. LRFC vs CELU Comparison

LRFC vs CELU Comparison

Compare LRFC & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRFC
  • CELU
  • Stock Information
  • Founded
  • LRFC 2013
  • CELU 2016
  • Country
  • LRFC United States
  • CELU United States
  • Employees
  • LRFC N/A
  • CELU N/A
  • Industry
  • LRFC Finance: Consumer Services
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • LRFC Finance
  • CELU Health Care
  • Exchange
  • LRFC Nasdaq
  • CELU Nasdaq
  • Market Cap
  • LRFC 50.2M
  • CELU 42.2M
  • IPO Year
  • LRFC 2013
  • CELU N/A
  • Fundamental
  • Price
  • LRFC $19.00
  • CELU $2.00
  • Analyst Decision
  • LRFC
  • CELU
  • Analyst Count
  • LRFC 0
  • CELU 0
  • Target Price
  • LRFC N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • LRFC 11.1K
  • CELU 73.1K
  • Earning Date
  • LRFC 08-07-2025
  • CELU 05-08-2025
  • Dividend Yield
  • LRFC 7.56%
  • CELU N/A
  • EPS Growth
  • LRFC N/A
  • CELU N/A
  • EPS
  • LRFC N/A
  • CELU N/A
  • Revenue
  • LRFC $20,544,000.00
  • CELU $54,220,000.00
  • Revenue This Year
  • LRFC N/A
  • CELU $23.29
  • Revenue Next Year
  • LRFC N/A
  • CELU N/A
  • P/E Ratio
  • LRFC N/A
  • CELU N/A
  • Revenue Growth
  • LRFC 3.11
  • CELU 138.11
  • 52 Week Low
  • LRFC $16.57
  • CELU $1.00
  • 52 Week High
  • LRFC $26.00
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • LRFC 56.05
  • CELU 55.51
  • Support Level
  • LRFC $18.53
  • CELU $1.80
  • Resistance Level
  • LRFC $19.00
  • CELU $2.15
  • Average True Range (ATR)
  • LRFC 0.39
  • CELU 0.17
  • MACD
  • LRFC 0.18
  • CELU 0.01
  • Stochastic Oscillator
  • LRFC 77.87
  • CELU 75.66

About LRFC Logan Ridge Finance Corporation

Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: